MANNUCCI, PIER MANNUCCIO
MANNUCCI, PIER MANNUCCIO
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Rare inherited coagulation disorders: no longer orphan and neglected
2024 S. Mohsenian, P.M. Mannucci, M. Menegatti, F. Peyvandi
Mortality during the SARS-CoV-2 Pandemic: A Comparative Analysis between Lombardy in Italy and Israel
2024 R. Najjar-Debbiny, A. Nobili, P. Mannuccio Mannucci, O. Barnett-Griness, W. Saliba, Y. Adir, A. Antonella Galbussera, M. Tettamanti, B. D'Avanzo, S. Harari
Hemophilia patients: are they naturally anticoagulated?
2023 A. Tripodi, P.M. Mannucci, F. Peyvandi
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
2023 M.T. Pagliari, U. Budde, L. Baronciani, P. Eshghi, M. Ahmadinejad, Z. Badiee, M. Baghaipour, O. Benítez Hidalgo, E. Biguzzi, I. Bodó, G. Castaman, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, P.M. Mannucci, A.B. Federici, J. Eikenboom, F. Peyvandi
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both
2023 E. Crisafulli, G. Sartori, A. Vianello, F. Busti, A. Nobili, P.M. Mannucci, D. Girelli
Air pollution and cardiovascular health in Middle East and North Africa: many shadows but some light
2023 P.M. Mannucci, F. Peyvandi
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding
2023 S. Pasca, E. Zanon, P.M. Mannucci, F. Peyvandi
Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients
2023 R. Rossio, S. Mandelli, I. Ardoino, A. Nobili, F. Peyvandi, P.M. Mannucci, C. Franchi
Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact
2023 A. Nobili, B. D'Avanzo, M. Tettamanti, A.A. Galbussera, G. Remuzzi, I. Fortino, O. Leoni, S. Harari, P.M. Mannucci
Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
2023 E.A. Boccalandro, S. Pasca, V. Begnozzi, R. Gualtierotti, P.M. Mannucci
Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy
2023 P.M. Mannucci, A.A. Galbussera, B. D'Avanzo, M. Tettamanti, G. Remuzzi, I. Fortino, O. Leoni, S. Harari, A. Nobili
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
2022 M.T. Pagliari, F.R. Rosendaal, M. Ahmadinejad, Z. Badiee, M. Baghaipour, L. Baronciani, O. Benítez Hidalgo, I. Bodó, U. Budde, G. Castaman, P. Eshghi, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, P.M. Mannucci, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, F. Peyvandi, A.B. Federici, J. Eikenboom
Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry
2022 C. Argano, G. Natoli, S. Mularo, A. Nobili, M.L. Monaco, P.M. Mannucci, F. Perticone, A. Pietrangelo, S. Corrao
Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy
2022 P.M. Mannucci, A. Nobili, M. Tettamanti, B. D'Avanzo, A.A. Galbussera, G. Remuzzi, I. Fortino, O. Leoni, S. Harari
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients
2022 S. Cicco, M. D Abbondanza, M. Proietti, V. Zaccone, C. Pes, F. Caradio, M. Mattioli, S. Piano, A.M. Marra, A. Nobili, P.M. Mannucci, A. Pietrangelo, G. Sesti, E. Buzzetti, A. Salzano, A. Cimellaro
Progressive decrease of the healthcare impact of the post-COVID condition after the first disease wave in Lombardy, Italy
2022 P.M. Mannucci, A. Nobili, M. Tettamanti, B. D'Avanzo, A.A. Galbussera, G. Remuzzi, I. Fortino, O. Leoni, S. Harari
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment
2021 R. Rossio, M. Tettamanti, A. Nobili, S. Harari, P.M. Mannucci, A. Bandera, F. Peyvandi, S. Bosari, L. Scudeller, G. Fusetti, L. Rusconi, S. Dell'Orto, D. Prati, L. Valenti, S. Giovannelli, M. Manunta, G. Lamorte, F. Ferrari, A. Gori, A. Muscatello, D. Mangioni, L. Alagna, G. Bozzi, A. Lombardi, R. Ungaro, G. Ancona, G. Zuglian, M. Bolis, N. Iannotti, S. Ludovisi, A. Comelli, G. Renisi, S. Biscarini, V. Castelli, E. Palomba, M. Fava, V. Fortina, C.A. Peri, P. Saltini, G. Viero, T. Itri, V. Ferroni, V. Pastore, R. Massafra, A. Liparoti, T. Muheberimana, A. Giommi, R. Bianco, R.M. De Azevedo, G.E. Chitani, R. Gualtierotti, B. Ferrari, N. Boasi, E. Pagliaro, C. Massimo, M. De Caro, A. Giachi, N. Montano, B. Vigone, C. Bellocchi, A. Carandina, E. Fiorelli, V. Melli, E. Tobaldini, F. Blasi, S. Aliberti, M. Spotti, L. Terranova, S. Misuraca, A. D'Adda, S.D. Fiore, M. Di Pasquale, M. Mantero, M. Contarini, M. Ori, L. Morlacchi, V. Rossetti, A. Gramegna, M. Pappalettera, M. Cavallini, A. Buscemi, M. Vicenzi, I. Rota, G. Costantino, M. Solbiati, L. Furlan, M. Mancarella, G. Colombo, G. Colombo, A. Fanin, M. Passarella, V. Monzani, C. Canetta, A. Rovellini, L. Barbetta, F. Billi, C. Folli, S. Accordino, D. Maira, C.M. Hu, I. Motta, N. Scaramellini, A.L. Fracanzani, R. Lombardi, A. Cespiati, M. Cesari, T. Lucchi, M. Proietti, L. Calcaterra, C. Mandelli, C. Coppola, A. Cerizza, A.M. Pesenti, G. Grasselli, A. Galazzi, I. Monti, A.A. Galbussera, E. Crisafulli, D. Girelli, A. Maroccia, D. Gabbiani, F. Busti, A. Vianello, M. Biondan, F. Sartori, P. Faverio, A. Pesci, S. Zucchetti, P. Bonfanti, M. Rossi, I. Beretta, A. Spolti, D. Elia, R. Cassandro, A. Caminati, F. Cipollone, M.T. Guagnano, D. D'Ardes, I. Rossi, F. Vezzani, A. Spanevello, F. Cherubino, D. Visca, M. Contoli, A. Papi, L. Morandi, N. Battistini, G.L. Moreo, P. Iannuzzi, D. Fumagalli, S. Leone
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
2021 L. Baronciani, I. Peake, R. Schneppenheim, A. Goodeve, M. Ahmadinejad, Z. Badiee, M.-. Baghaipour, O. Benitez, I. Bodo, U. Budde, A. Cairo, G. Castaman, P. Eshghi, J. Goudemand, W. Hassenpflug, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F.L. Fernandez, P.M. Mannucci, R. Marino, N. Niksic, F. Oyen, C. Santoro, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, E.M.K. Zetterberg, J. Eikenboom, A.B. Federici, F. Peyvandi
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients
2021 A. Gigante, M. Proietti, E. Petrillo, P.M. Mannucci, A. Nobili, M. Muscaritoli
Von Willebrand disease type 2N: An update
2021 O. Seidizadeh, F. Peyvandi, P.M. Mannucci